BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion

In The News
June 3, 2024

Ropes & Gray represented Becton, Dickinson and Company, BD, in a definitive agreement to acquire Edwards Lifesciences' Critical Care product group, a leader in advanced hemodynamic monitoring solutions, for $4.2 billion in cash. The transaction was announced in a June 3 press release.

The complementary acquisition will expand BD's portfolio of smart connected care solutions with a broad set of hemodynamic monitoring technologies, advanced AI-enabled clinical decision tools and a robust innovation pipeline. BD is one of the largest global medical technology companies in the world, with more than 70,000 employees.

The team included mergers & acquisitions partners Emily Oldshue and Marko Zatylny and associate Tyler Silvey, life sciences intellectual property and licensing partner Amanda Austin and counsel Georgina Jones Suzuki, tax partner Benjamin Rogers, executive compensation & employee benefits partner Jenny Rikoski Whitney, antitrust partners Jonathan Klarfeld and Ruchit Patel, healthcare partner Jennifer Romig, data, privacy & cybersecurity partner Ed McNicholas, life sciences regulatory & compliance partners Josh Oyster, Lincoln Tsang and Katherine Wang, employment partner Richard Kidd and real estate partner David Kaye.